Jena, Germany

Sven Ring

USPTO Granted Patents = 27 

 

 

Average Co-Inventor Count = 5.3

ph-index = 6

Forward Citations = 175(Granted Patents)


Location History:

  • Berlin, DE (2018)
  • Jena, DE (1998 - 2019)

Company Filing History:


Years Active: 1998-2019

Loading Chart...
Loading Chart...
Loading Chart...
27 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Sven Ring: A Profile of a Notable Inventor

Introduction: Sven Ring, based in Jena, Germany, is a distinguished inventor with an impressive portfolio of 27 patents. His work predominantly focuses on developing new pharmaceutical compounds, particularly in the field of treating neoplasms, demonstrating a strong commitment to advancing medical research and innovation.

Latest Patents: Among Sven Ring's noteworthy contributions are his latest patents:

1. **Benzimidazol-2-amines as mIDH1 inhibitors** - This patent encompasses the development of benzimidazol-2-amines of a specific general formula. It details methods for preparing these compounds, their intermediate compounds, pharmaceutical compositions, and their application in treating diseases, especially neoplasms, either as standalone agents or in conjunction with other active ingredients.

2. **5-hydroxyalkylbenzimidazoles as mIDH1 inhibitors** - Similar to the previous patent, this invention also deals with benzimidazol-2-amines of a corresponding general formula. It outlines the methods of preparation, the associated intermediate compounds, and their pharmaceutical uses for disease treatment, particularly focusing on neoplasms.

Career Highlights: Sven Ring has made significant contributions to the pharmaceutical industry through his tenure at notable companies. He has spent a considerable amount of time at Schering Aktiengesellschaft and Bayer Pharma Aktiengesellschaft, where his innovative endeavors have laid the foundation for numerous advancements in medicinal chemistry.

Collaborations: Throughout his career, Sven Ring has collaborated with esteemed professionals in the field, including Walter Elger and Gerd Schubert. These partnerships have not only enriched his research but have also resulted in groundbreaking developments in the pharmaceutical sector.

Conclusion: Sven Ring's exemplary contributions to the field of pharmaceutical innovations position him as a key figure in contemporary research. His 27 patents, particularly those targeting neoplasms, underline the vital role of inventors in the quest for effective treatments. The legacy of his work continues to inspire future generations of scientists and inventors in their pursuit of medical advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…